Proteinaceous fibrillar deposits accumulate in the brain before the onset and during the progression of several common ageing-associated neurodegenerative diseases (Josephs et al., 2009; Vlad et al., 2012) . Relationships between the pathological proteins and overt disease remain unclear. As most chronic neurodegenerative diseases progress over years or even decades, pathological aggregates of proteins might produce different effects at different stages (Ballatore et al., 2007; Kirby et al., 2010) . Aggregates of specific proteins are used to define some common human neurodegenerative diseases: b-amyloid (Ab) plaques with neurofribrillary tangles (NFTs) of hyperphosphorylated tau (p-tau) protein in Alzheimer's disease (AD), and Lewy bodies of a-synuclein in Parkinson's and other diseases. Aggregates of abnormal prion protein (PrP TSE ) are a hallmark of transmissible spongiform encephalopathies (TSEs; prion diseases) (Prusiner, 1982; Vlad et al., 2012) . More than one protein might interact, accelerating progression of disease, e.g. normal PrP (PrP C ) is a high-affinity binding site for Ab, suggesting that PrP C might feature in the pathogenesis of AD (Nygaard & Strittmatter, 2009; Fluharty et al., 2013; Forloni et al., 2013) . Tau and a-synuclein each promote aggregation of the other (Giasson et al., 2003) . Ab seems to promote hyperphosphorylation of tau via downregulation of the insulin signalling pathway in the brain (Tokutake et al., 2012) . Thus, interactions between endogenous proteins in the central nervous system (CNS), whilst complex and poorly understood, probably play some role in neurodegeneration. Transgenic mice and cell cultures expressing mutant proteins yielded interesting information about genetic neurodegenerative diseases. However, most neurodegenerative diseases of humans are sporadic, without mutations or overexpression of proteins (Balducci & Forloni, 2011; Gilley et al., 2011) . Experimental models in WT animals genetically close to humans might help elucidate complex proteinopathies.
We reported previously that squirrel monkeys (SQs) infected with the classical bovine spongiform encephalopathy (BSE) agent (SQ-BSE) developed an encephalopathy resembling variant Creutzfeldt-Jakob disease (vCJD) in humans (Piccardo et al., 2011 . Here, we describe a neuropathologic study using site-and phosphorylationspecific antibodies for topographical analysis of p-tau by immunohistochemistry (IHC) and correlations with pathological features in SQ-BSE. In addition, tissue sections were probed with antibodies to apolipoprotein-E (Apo-E), a-synuclein, ubiquitin and synaptophysin (Table 1) . A polyclonal antibody to bovine glial fibrillary acidic protein (GFAP) was also used (Table 1) . IHC was performed using previously described protocols . Immunoreactivity was scored semiquantitatively by a fourpoint scale modified from Fraser & Dickinson (1967) . Selected brain sections were treated with thioflavin-s to detect amyloid. In addition, formalin-fixed tissues from spleen, liver and kidney were used for histopathologic and immunohistochemical studies. Tissue sections were probed with anti-PrP antibodies 3F4 and 6H4 (Table 1 ).
Neuropathologic studies showed that PrP TSE , p-tau and a-synuclein were deposited mainly at the periphery of vacuoles in the neuropil, affecting the same regions that had spongiform degeneration. All sections probed with the various anti-tau antibodies showed a similar staining pattern. (Figs 1c, d , 2a, b and 3, Table 2 ). No p-tau or asynuclein was detected in SQs without TSE. IHC in brain sections of SQ-BSE without primary antibody was nonreactive, indicating that staining of tau and a-synuclein was specific. All six SQ-BSEs showed more PrP TSE (diffuse synaptic-like, pericellular and coarse deposits without amyloid properties) than p-tau and a-synuclein, suggesting that dose-dependent toxicity triggered by PrP TSE led to neurodegeneration. (Figs 2d and 3) . Interestingly, no samples from SQ-BSEs reacted with antibodies to 3-repeat tau (RD3); 4-repeat tau (RD4) showed only limited staining -most prominent in a SQ-BSE with shortest incubation period (29 months) and longest duration of illness (5 months). The frontal cortex, thalamus and hypothalamus showed the most severe spongiform degeneration and accumulations of aggregated proteins (Table 2) . Similar, but less intense, deposits occurred in molecular, granular and Purkinje cell layers of the cerebellum and in the brainstem, co-localized with intense spongiform degeneration. Similar aggregates of p-tau and a-synuclein were seen to occur in many neurodegenerative and lipid storage diseases, such as Niemann-Pick (Bu et al., 2002) . Protein accumulation was minimal or absent in hippocampus and temporal cortex (areas with little or no spongiform degeneration or PrP TSE accumulation). When present, spongiform degeneration in the hippocampus was restricted to an area of the stratum lacunosum-moleculare. p-Tau and a-synuclein deposits always occurred in the same areas of the hippocampus with spongiform degeneration and PrP TSE , suggesting a strong correlation. 
Complex proteinopathy in monkeys with BSE
Sparing of the temporal cortex was confirmed by the finding that synaptophysin (fine granular and evenly distributed) remained unaffected in this cortical area, but was reduced and moderately disorganized in areas with severe spongiform degeneration accompanied by complex protein aggregates (PrP TSE , p-tau, ubiquitin and a-synuclein) and severe gliosis. To explore whether p-tau and a-synuclein colocalized, we double-stained brain sections from one SQ-BSE; for controls, we probed adjacent brain sections without primary antibody and brain sections from a SQ without TSE. Punctate and rod-shaped p-tau (AT8-reactive) and asynuclein deposits co-localized in areas with severe spongiform degeneration (Fig. 4) .
We detected no fibrillar oligomers (with antibody OC, recognizing epitopes common to various amyloid fibrils) and no Ab-or Apo-E in any brain region of any SQ-BSE apart from one with a single small Ab plaque in the temporal cortex (Table 2) . We did observe discrete isolated areas of OC-reactive and Ab plaque-like structures in the frontal and temporal cortical neuropil of one control SQ (without TSE). Normal ageing monkeys develop Ab amyloid deposits in the brain (Walker et al., 1990 ), so we suspect that, Ab and fibrillar oligomers in the control were age-related. No PrP immunopositivity was detected in any of the peripheral organs analysed.
The SQ-BSE model offers an opportunity to investigate several important issues associated with neurodegeneration: (i) pathogenesis of protein misfolding diseases, (ii) antemortem diagnosis and (iii) therapy. In SQ-BSE, neurotoxicity may well depend on post-translational modifications of brain proteins before PrP amyloid, p-tau NFTs and intracellular a-synuclein inclusions form. In all six SQ-BSEs, protein aggregated into fine granular and rod-shaped deposits in the cerebrum, cerebellum and brainstem. Ab and Apo-E did not accumulate; this is not surprising because p-tau, for example, also accumulates without Ab in primary tauopathies (Ludolph et al., 2009) . We observed no florid plaques -a typical although non-specific feature in brains of patients with vCJD and macaques with BSE (Lasmézas et al., 1996 (Lasmézas et al., , 2001 (Lasmézas et al., , 2005 Will et al., 1996; Shimizu et al., 1999) , but not in brains of cows, felines and mice with BSE (Wells et al., 1987; Williams et al., 2007) -showing that the host determines some important neuropathologic features of a TSE.
In our model, the co-localization of several proteins involved in neurodegeneration suggests that misfolding of one protein (probably PrP TSE ) induced post-translational changes of other proteins, p-tau and a-synuclein, consistent with a report that the N terminus and repeat regions of tau interact with the octapeptide-repeat region of PrP to form heterologous protein aggregates (Wang et al., 2008) . Tau and a-synuclein are intrinsically unstructured brain proteins (Nath et al., 2012) -tau a microtubule-associated protein stabilizing axonal microtubules in axons and a-synuclein localizing in axonal terminals. Another study found that a-synuclein induced the formation of tau fibrils and both molecules synergistically affected polymerization of the other (Giasson et al., 2003) . p-Tau and a-synuclein might co-localize due to synergistic aggregation following the formation of PrP TSE . The consistent presence of mixed protein aggregates in a TSE suggests a possible common pathological pathway to neurodegeneration: if several neurodegenerative diseases share it, that pathway might offer a therapeutic target. Many studies have characterized PrP TSE associated with infectivity, but few have elucidated how PrP TSE actually damages the CNS. Several forms of PrP TSE were recently proposed as possibly neurotoxic (Jeffrey et al., 2012; Zhou et al., 2012) . Brains of SQ-BSEs contained neither fibrillar oligomers nor mature amyloid, implying that severe neurodegeneration more likely resulted from smaller non-fibrillar PrP TSE species. Whether there are different PrP TSE species, one associated with infectivity and another causing neurotoxicity, remains unknown. All six SQ-BSEs developed a complex proteinopathy lacking important neuropathologic features common to several other human neurodegenerative diseases. For example, brains of patients with Gerstmann-Sträussler-Scheinker disease, particularly those with PrP mutations F198S and Q217R, consistently accumulate PrP TSE amyloid with p-tau (NFTs identical to those in AD). Neuropil of SQ-BSE contained grains of RD4 resembling those of argyrophilic grain disease (AGD) -a common neurodegenerative disease of old age (Ferrer et al., 2008) . Whilst AGD mainly affects the limbic system, SQ-BSE preferentially affected the frontal cortex. SQ-BSE never shows p-tau deposits resembling those of progressive supranuclear palsy (Ince et al., 2008) , astrocytic plaques of corticobasal degeneration (Togo et al. 2002; Lowe et al., 2008) or a-synuclein-staining Lewy bodies (Ghetti et al., 1989 (Ghetti et al., , 1996a Tagliavini et al., 1993; Wittmann et al., 2001; Bautista et al., 2006; Ferrer et al., 2008; Giaccone et al., 2008; Jayadev et al., 2011; Reiniger et al., 2011) . The tauopathy and a-synucleinopathy in SQ-BSE affected not only the cerebrum, but also the cerebellum -an area only recently recognized with tauopathy in TSEs and other neurodegenerative diseases (Giaccone et al., 2008; Furuoka et al., 2011; Reiniger et al., 2011; Sepulveda-Falla et al., 2011) . In conclusion, the histopathology of SQ-BSE Studies of cerebrospinal fluid (CSF) from patients with TSEs and other neurodegenerative diseases have sought molecular markers for ante-mortem diagnosis of dementias, especially the 14-3-3 group of proteins often increased in the CSF of patients with CJD, acute stroke, CNS infections and other inflammatory diseases, but less often in AD (Hsich et al., 1996; Zanusso et al., 2005; Bersano et al., 2006) . A positive 14-3-3 protein assay, together with clinical features, sometimes aids in the differential diagnosis of sporadic CJD. Some dementing diseases were found to have typical profiles of several other proteins in the CSF (Green et al., 2010; Zanusso et al., 2011) , e.g. elevated p-tau with Thr181 in the CSF of patients with vCJD (Goodall et al., 2006) . p-Tau aggregates reacted strongly with antibody AT270, directed to p-tau Thr181, throughout the cerebrum and cerebellum of every SQ-BSE. The finding of elevated p-tau in vCJD CSF also suggests that abnormal tau might affect pathogenesis. Detecting abnormal tau might improve CSF tests for the differential diagnosis of neurodegenerative diseases (Zanusso et al., 2011; Green et al., 2010) .
In conclusion, topographic analysis of the brains of six SQ-BSEs showed a close correlation between the degree of spongiform degeneration, PrP TSE , and deposits of p-tau, a-synuclein and ubiquitin, but not Ab. Whether or not p-tau and a-synuclein contribute to progression of TSEs or result from brain damage remains to be determined. The complete absence of mature amyloid, in spite of severe proteinopathy, in all SQ-BSEs suggests that oligomeric aggregates of PrP and other proteins are probably the most pathogenic species. 
